NANOCAS
Live / Applied — Fifth extension granted (statement of use) (as of 31 Dec 2025)
What this means for you
Not registered yet, but its 25 Mar 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97330825
- Mark type
- Stylized text
- Filed
- 25 Mar 2022
- Published for opposition
- 14 Feb 2023
- Attorney of record
- Brian Davis
Goods and services
- Class 001 — Chemicals: Enzymes for scientific and research purposes
- Class 005 — Pharmaceuticals: Enzymes for use as a gene editor for therapeutics
Owner
- Mammoth Biosciences, Inc., Brisbane, CA, US
- Mammoth Biosciences, Inc., Brisbane, CA, US
Prosecution history
- 31 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 31 Dec 2025 — SOU EXTENSION 5 GRANTED
- 17 Aug 2025 — SOU EXTENSION 5 FILED
- 31 Dec 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 18 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 18 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Mar 2025 — SOU EXTENSION 4 GRANTED
- 18 Mar 2025 — SOU EXTENSION 4 FILED
- 18 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 07 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Oct 2024 — SOU EXTENSION 3 GRANTED
- 07 Oct 2024 — SOU EXTENSION 3 FILED
- 07 Oct 2024 — SOU TEAS EXTENSION RECEIVED
- 11 Apr 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Apr 2024 — SOU EXTENSION 2 GRANTED